Xia Y, Sun M, Huang H, Jin W
Signal Transduct Target Ther. 2024; 9(1):92.
PMID: 38637540
PMC: 11026526.
DOI: 10.1038/s41392-024-01808-1.
Henry B, Lippi G, Nasser A, Ostrowski P
Curr Oncol. 2023; 30(6):5932-5945.
PMID: 37366926
PMC: 10297460.
DOI: 10.3390/curroncol30060443.
Tini P, Marampon F, Giraffa M, Bucelli S, Niyazi M, Belka C
Radiat Oncol. 2023; 18(1):62.
PMID: 37016421
PMC: 10074717.
DOI: 10.1186/s13014-023-02243-2.
Margas W, Wojciechowski P, Toumi M
J Mark Access Health Policy. 2022; 10(1):2106627.
PMID: 35968522
PMC: 9367669.
DOI: 10.1080/20016689.2022.2106627.
Truong T, Panizzutti B, Kim J, Walder K
Pharmaceutics. 2022; 14(7).
PMID: 35890359
PMC: 9319329.
DOI: 10.3390/pharmaceutics14071464.
Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay.
Cipriani C, Pacheco M, Kishk A, Wachich M, Abankwa D, Schaffner-Reckinger E
Pharmaceuticals (Basel). 2022; 15(2).
PMID: 35215292
PMC: 8875459.
DOI: 10.3390/ph15020179.
Predicting completion of clinical trials in pregnant women: Cox proportional hazard and neural network models.
Kim B, Jang Y, Cho H, Kim S, Jeong J, Shim M
Clin Transl Sci. 2021; 15(3):691-699.
PMID: 34735737
PMC: 8932703.
DOI: 10.1111/cts.13187.
Uncontrolled Extensions of Clinical Trials and the Use of External Controls-Scoping Opportunities and Methods.
Wang C, Berlin J, Gertz B, Davis K, Li J, Dreyer N
Clin Pharmacol Ther. 2021; 111(1):187-199.
PMID: 34165790
PMC: 9290853.
DOI: 10.1002/cpt.2346.
Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008-2019.
Zhong Y, Zhang X, Zhou L, Li L, Zhang T
BMC Pediatr. 2021; 21(1):212.
PMID: 33931029
PMC: 8086350.
DOI: 10.1186/s12887-021-02658-4.
SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
Jarada T, Rokne J, Alhajj R
BMC Bioinformatics. 2021; 22(1):28.
PMID: 33482713
PMC: 7821180.
DOI: 10.1186/s12859-020-03950-3.
A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions.
Jarada T, Rokne J, Alhajj R
J Cheminform. 2021; 12(1):46.
PMID: 33431024
PMC: 7374666.
DOI: 10.1186/s13321-020-00450-7.
Obstacles to the reuse of study metadata in ClinicalTrials.gov.
Miron L, Goncalves R, Musen M
Sci Data. 2020; 7(1):443.
PMID: 33339830
PMC: 7749162.
DOI: 10.1038/s41597-020-00780-z.
Phenotype-oriented network analysis for discovering pharmacological effects of natural compounds.
Yoo S, Nam H, Lee D
Sci Rep. 2018; 8(1):11667.
PMID: 30076354
PMC: 6076245.
DOI: 10.1038/s41598-018-30138-w.
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov.
Cihoric N, Tsikkinis A, Minniti G, Lagerwaard F, Herrlinger U, Mathier E
Radiat Oncol. 2017; 12(1):1.
PMID: 28049492
PMC: 5210306.
DOI: 10.1186/s13014-016-0740-5.
Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry.
Zhang X, Zhang Y, Ye X, Guo X, Zhang T, He J
BMJ Open. 2016; 6(11):e010643.
PMID: 27881517
PMC: 5168517.
DOI: 10.1136/bmjopen-2015-010643.
Extracting genetic alteration information for personalized cancer therapy from ClinicalTrials.gov.
Xu J, Lee H, Zeng J, Wu Y, Zhang Y, Huang L
J Am Med Inform Assoc. 2016; 23(4):750-7.
PMID: 27013523
PMC: 4926744.
DOI: 10.1093/jamia/ocw009.
Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database.
Cihoric N, Tsikkinis A, Gutierrez Miguelez C, Strnad V, Soldatovic I, Ghadjar P
Radiat Oncol. 2016; 11:48.
PMID: 27005770
PMC: 4804566.
DOI: 10.1186/s13014-016-0624-8.
Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981-2012.
Travers K, Sallum R, Burns M, Barr C, Beattie M, Pashos C
Pharmacoepidemiol Drug Saf. 2014; 24(4):389-98.
PMID: 25079108
PMC: 4407929.
DOI: 10.1002/pds.3643.
Clinical trials in systemic lupus erythematosus: a status report on ongoing trials.
Gumber D, Paul J, Ranganathan P
Rheumatol Int. 2014; 34(12):1633-8.
PMID: 24752544
DOI: 10.1007/s00296-014-3018-y.
Non-publication of large randomized clinical trials: cross sectional analysis.
Jones C, Handler L, Crowell K, Keil L, Weaver M, Platts-Mills T
BMJ. 2013; 347:f6104.
PMID: 24169943
PMC: 3812466.
DOI: 10.1136/bmj.f6104.